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Background: To determine the antiproliferative effect of gamma-tocotrienol (GTT) treatment on differential protein
expression in HepG2 cells.
Methods: HepG2 cells were treated with 70 μM GTT for 48 hours and differentially expressed protein spots were
determined by two-dimensional electrophoresis (2DE), identified by MALDI-TOF mass spectrometer (MS) and
validated by quantitative real-time polymerase chain reaction (qRT-PCR).
Results: GTT treatment on HepG2 cells showed a total of five differentially expressed proteins when compared to
their respective untreated cells where three proteins were down-regulated and two proteins were up-regulated.
One of these upregulated proteins was identified as peroxiredoxin-4 (Prx4). Validation by qRT-PCR however showed
decreased expression of Prx4 mRNA in HepG2 cells following GTT treatment.
Conclusions: GTT might directly influence the expression dynamics of peroxiredoxin-4 to control proliferation in
liver cancer.
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Gamma-tocotrienol (GTT) is a member of the vitamin E
family and has been reported to have antiproliferative
effect against a wide variety of tumor cells such as breast
cancer cells [1], human leukemia cells [2], mammary
malignant epithelial cells [3], human cervical carcinoma
cells [4] and liver cancer cells [5]. Several possible mech-
anisms have been proposed to explain the antiprolifera-
tive activity of GTT either through its antioxidant effect
[6,7], enzyme suppression [8,9], pro-apoptotic effects
[10,11], mitogenesis regulation [2] or anti-angiogenic
activity [12]. In breast cancer cells GTT inhibited the
nuclear factor kappa beta (NF-κB) activation pathway,
leading to the down-regulation of various NF-κB-
downstream targets that support cell survival (IAP1,
IAP2, Bcl-xL, Bcl-2, cFLIP, XIAP, Bfl-1/A1, TRAF1, and* Correspondence: zakiah@medic.ukm.my
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article, unless otherwise stated.survivin) and proliferation (cyclin D1, COX2, and c-Myc)
besides potentiating apoptosis [13]. The involvement of
multiple signaling pathways (NF-κB and JNK) and pro-
teins (EGF-R, Id-1 and Id-3) was suggested to explain the
antiproliferative effect of GTT in prostate cancer (PCa)
cells [14].
Tocotrienols especially δ- and γ-tocotrienol (GTT)
modulates cellular redox status by regulating the expres-
sion levels of antioxidant enzymes. GTT increases the
expression of several antioxidant enzymes such as thior-
edoxin and quinine reductase 2 (NQO2) while suppress-
ing the growth of MCF-7 cells [15]. In MDA-MB-231
cells, treatment by tocotrienols led to several fold in-
crease of NRF2 expression marked by corresponding de-
crease in Kelch-like ECH-associated protein 1 (KEAP1)
levels [15]. Major intracellular antioxidants such as
glutathione, superoxide dismutase and catalase have long
been recognized as part of our body’s detoxification
mechanisms. However, a recently identified novel anti-
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the use of electrons provided by a thioredoxin or a glu-
taredoxin [16].
Prx exists as six unique isoforms (PrxI to VI) in mam-
malian cells. They exhibit different expression patterns
during development, distribute differently in organelles,
and undergo different reaction intermediates during
catalysis [17]. Some of these isoforms provide defence
against oxidative damage and others appear to partici-
pate in signalling by controlling H2O2 concentration
[17]. A connection between Prx and vitamin has recently
been established by Tolle et al. [18]. They reported that
the expression of Prx1 and Prx6 is selectively regulated
in alveolar type II cells isolated from vitamin E-depleted
rats, depending on the severity of oxidative load. Another
study by Dahlan et al. [19] suggested that tocotrienol rich
fraction directly influenced the expression dynamics of
peroxiredoxin-2 in H2O2 challenged lymphocyte cells to
improve the cells ability to resist oxidative damage. This
suggested that peroxiredoxins are regulated by vitamin E
in coping with oxidative stress. The antiproliferative
effect of GTT in rat hepatoma dRLh-84 cells and human
hepatoma Hep3B cells were reported by Sakai et al.
[20,21], in murine liver cancer cells, BNL 1ME A.7R.1 by
Har and Keong [22], and in HepG2 cells by Aida et al.
[5]. Our earlier study on the HepG2 cell line showed that
GTT increased Ras protein expression [5]. Sakai et al.
[20,21] and Har and Keong [22], demonstrated a rise in
caspases activity during apoptosis induction in several
liver cancer cell lines being treated with GTT.
Thus, with that in mind this study we aim to deter-
mine the changes in protein expression involved in the
antiproliferative activity of GTT in HepG2 cells.
Methods
Cell culture and GTT treatment
Hepatoma HepG2 cell lines from the American Type
Culture Collection (ATCC, USA) was maintained in Eagle
minimum essential medium (EMEM, Flowlab, Australia)
containing 10% fetal calf serum (PAA, Austria), penicillin/
streptomycin (100 μg/ml) (Flowlab, Australia) at 37°C in
an atmosphere containing 5% CO2. On reaching conflu-
ence, cells were trypsinized, centrifuged and counted
using a haemocytometer. Cells were then plated at a con-
sistent density of 2 × 106 cells/100-mm culture plates for
every treatment group.
Gamma tocotrienol was supplied by Malaysian Palm
Oil Board (MPOB). Stock solution of GTT (0.5 M) was
prepared in 100% ethanol and stored as small aliquots at
−20°C. Prior to use, GTT from the stock solution was
mixed with fetal calf serum and incubated overnight at
37°C. The GTT was then diluted to a 70 μM solution in
a mixture of culture medium and 100% ethanol where
the final ethanol concentration was less than 0.05%.Cells with the density and condition as stated above
were left untreated or treated with GTT at 70 μM final
concentration for 48 hours. Untreated cells were cul-
tured only in EMEM without GTT. All treatments were
done in triplicate and the experiments were repeated
thrice.
Sample preparation for 2DE
After 48 hours of GTT treatment, cells were harvested
by trypsinization and transferred into 15 ml falcon cen-
trifuge tubes. The cells were harvested by centrifugation
at 800 rpm for 10 minutes. The resulting pellet was then
washed thrice with cold phosphate buffered saline (PBS).
It was then re-suspended in 200 μl lysis buffer (8 M
urea, 2% CHAPS, 0.5% pH 4–7 IPG buffer, Amersham,
USA) containing protease inhibitor mix (Amersham,
USA). The cells were then incubated on ice for 30 mi-
nutes with intermittent vortexing at 10 minute intervals.
After centrifugation at 13000 rpm for 30 minutes at 4°C,
the supernatant was transferred to sterile microcentri-
fuge tubes. Protein concentration was determined by
Bradford assay (1976) [23].
Two-dimensional gel electrophoresis (2DE)
First dimension separation was carried out on immobi-
lized pH gradient (IPG) strips (24 cm, linear, pH 4–7,
GE Healthcare Bio-Sciences, Uppsala, Sweden) with
Ettan IPGphor II Isoelectric Focusing System and stand-
ard strip holder (GE Healthcare Bio-Sciences, Uppsala,
Sweden). IPG strips pH 4–7 were used for the 2DE
investigation because our preliminary study using pH 3–
10 strips indicated that the majority of most affected
proteins were found within this region (data not shown).
The use of 24 cm pH 4–7 IPG strips improved gel reso-
lution within this region compared to pH 3–10 strips.
Protein samples (80 μg) were loaded into sample cups at
the anode end. The IPG strips were then focused for a
total of 65 kVh. Upon completion of IEF, strips were
equilibrated in equilibration buffer (6 M urea, 75 mM
Tris–HCl, pH 8.8, 29.3% glycerol, 2% sodium dodecyl
sulphate (SDS), 0.002% bromophenol blue, 1% dithiotrei-
tol (DTT)) for 15 minutes, followed by the same buffer
containing 25% iodoacetamide instead of DTT for
another 15 minutes.
The second dimension separation was carried out at
15°C on 12.5% SDS slab gels using an ETTAN DALT II
electrophoresis system (GE Healthcare Bio-Sciences,
Uppsala, Sweden), with the IPG strips sealed on the top
of the gels with 0.5% agarose. Sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS-PAGE) was run
at constant power (1 W/gel) for 1 hour, then switched to
13 W/gel until the bromophenol blue marker reached
the bottom of the gel. For every treatment group, tripli-
cate runs were performed.
Table 1 Primers used in quantitative RT-PCR analysis of
proteins identified by 2DE
Protein Accession number Primer sequence 5′–3′
PRDX4 NM_006406.1 F: ccacttctacgcgggtggacaa
R: cagtagggcgctggcttggaaa
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Protein spots were visualized by silver staining as de-
scribed in the plus one silver staining kit (GE Healthcare
Bio-Sciences, Uppsala, Sweden). The complete protocol
was applied for analytical gels. For preparative gels, the
protocol was modified so that glutaraldehyde was omit-
ted from the sensitization step and formaldehyde omit-
ted from the silver reaction step. Images of stained
2DE-gels were acquired with a UMAX scanner, model
UTA-2100 XL and stored as tagged image file format
(TIFF) images. The 2DE maps were then analyzed
using the 2D Image Master Platinum software Version
6.0 (GE Healthcare Bio-Sciences, Uppsala, Sweden).
Only those spots that changed consistently by more
than 2.0 fold were selected as spots of interest.
In-gel tryptic digestion
Protein spots were excised and in-gel digested using
trypsin (Promega) for mass spectrometric analysis.
Briefly, excised spots were first destained in destaining
solution (15 mM potassium ferricyanide/50 mM sodium
thiosulphate, 1:1 [v/v]). The spots were then reduced in
a solution containing 10 mM DTT/100 mM ammonium
bicarbonate for 30 minutes at 60°C and alkylated in
55 mM iodoacetamide/100 mM ammonium bicarbonate
for 20 minutes in the dark. The gel pieces were then
washed (3 × 20 minutes) in 50% acetonitrile/100 mM
ammonium bicarbonate. This was followed by dehydra-
tion of the gel pieces in 100% acetonitrile and drying in
a vacuum centrifuge (SpeedVac, Thermo Scientific, Sav-
ant DNA 120). Subsequently the dried gel pieces were
rehydrated with 25 μl of 7 ng/μl trypsin (Promega tryp-
sin gold) in 50 mM ammonium bicarbonate buffer and
digested at 37°C for 18–20 h. Tryptic peptides were then
extracted using 50% acetonitrile for 15 minutes, followed
by 100% acetonitrile for 15 minutes. The extracted solu-
tions were then pooled into a single tube and dried in a
SpeedVac concentrator and solubilized with 10 μl of 10%
acetonitrile/40 mM ammonium bicarbonate.
MALDI-TOF/TOF mass spectrometer analysis and database
searching
Extracted proteins were first desalted using ziptip C18
(Millipore, USA) according to protocols described by the
manufacturer. The final elution volume following ziptip
clean up was 1.5 μl. The peptide samples were then
mixed (1:1) with a matrix consisting of a saturated solu-
tion of α-cyano-4-hydroxycinnamic acid (CHCA, Sigma)
prepared in 50% acetonitrile/0.1% trifluoroacetic acid.
Aliquots of samples (0.7 μl) were spotted onto stainless-
steel sample target plates. Peptide mass spectra were
obtained on a MALDI-TOF/TOF mass spectrometer
(ABI 4800 plus, Applied Biosystems) in the positive ion
reflector mode. For precursor ion selection, all fractionswere measured in a single MS before MS/MS was per-
formed. For MS/MS spectra, the peaks were calibrated
by default. The 20 most abundant precursor ions per
sample were selected for subsequent fragmentation by
high-energy collision-induced dissociation (CID). The
collision energy was set to 1 keV and the air was used as
the collision gas. The criterion for precursor selection
was a minimum S/N of 5. The mass accuracy was within
50 ppm for the mass measurement and 0.1 Da for CID
experiments. The other parameters for searching were of
trypsin, 1 missed cleavage, variable modification of carba-
midomethyl and oxidation of methionine, peptide charge
of 1+, and monoisotopic.
For database searches, known contamination peaks
such as keratin and auto proteolysis peaks for trypsin
were removed before searching. Spectra was processed
and analyzed by the Global Protein Server Explorer 3.6
software (Applied Biosystems). This uses an internal
MASCOT (Matrix Science, UK) program for matching
MS and MS/MS data against database information. The
data obtained were screened against human databases
downloaded from the Swiss-Prot/TrEMBL homepage
(http://www.expasy.ch/sprot).Quantitative real time RT-PCR analysis
Total ribonucleic acid (RNA) was extracted from HepG2
cells using TRIzol reagent according to the manufac-
turer’s instruction (Invitrogen, Paisley, United Kingdom).
The total RNA acted as template and was analyzed using
script one-step RT-PCR kit with SYBR Green (Biorad,
USA) according to the manufacturer’s protocols. Primers
were designed with Primer 3 software and blasted with
NCBI database sequences. The primers used are shown
in Table 1.
PCR amplification of identified gene, Prx4 was per-
formed by iQ5 Multicolor Real Time PCR System
(Biorad, USA) using the following program: cDNA
synthesis at 50°C for 20 minutes, iScript reverse tran-
scriptase inactivation at 95°C for 4 minutes followed
by 38 amplification cycles of denaturation melting at
95°C for 10 sec and 61°C (primer annealing and exten-
sion) for 30 sec. After the last cycle, a melting curve
analysis was generated at 95°C for 1 minute, 55°C for
1 minute and 60°C for 10 sec (70 cycles, increase set
point temperature after cycle 2 by 0.5°C). The expres-
sion levels of targeted genes were normalized against
Figure 2 Representative silver-stained 2DE gel for HepG2 cells
without GTT treatment at pH 4–7. The circled and numbered
proteins (1a, 2a and 3a) are the differentially expressed proteins. All
these three proteins were down-regulated during GTT treatment
and could not be detected in the protein profile of HepG2 cells with
GTT treatment.
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gel.
Quantitative real time PCR was performed to assess
the mRNA expression of Prx4 proteins. This performed
with samples from HepG2 cells with and without
48 hours of GTT treatment (70 μM).
Statistical analyses
Data for mRNA expression of Prx4 in Figure 1 was
expressed as mean ± S.D and differences between group
was statistically analyzed by t-test for independent sam-
ples parametric data distribution and considered signifi-
cant when p < 0.05. Data analysis was performed using
SPSS for Windows, version 17.
Results
Differential analysis of 2DE protein maps of HepG2 cells
The expression patterns of protein spots from HepG2
cells treated with GTT were compared to untreated con-
trol using 2DE image analysis software. Differential pro-
tein expression data were obtained from an independent
comparison of at least three pairs of gels obtained from
three independent cell growths. The analysis showed
that five protein spots were differentially expressed
(≥2.0-fold difference) in HepG2 cell lines compared to
untreated control groups. Three protein spots were
down-regulated (Figure 2) while two protein spots were
up-regulated (Figure 3) with GTT treatment. Out of five
protein spots (Table 2), MALDI-TOF/TOF was only able
to identify one protein spot which is protein A, peroxire-
doxin 4 (Table 3) that is shown in an enlarged diagram
in Figure 4.
Analysis of prx4 transcript level by qRT-PCR
Quantitative RT-PCR showed that the resulting relative
gene expression profiles were not similar to the proteinFigure 1 mRNA expressions of Prx4 in HepG2 cells. Results
represent the mean ± S.D. for three experiments. a indicates a
significant decrease of mRNA expression (p < 0.05) in GTT-treated
HepG2 cells compared to control untreated HepG2 cells.expression profiles observed in 2DE. On the contrary,
for HepG2 cells the relative expression observed was the
reverse of the protein expression observed in 2DE
(Figure 1).
Discussion
Profile changes in the cellular proteome induced by
GTT was observed on whole cell lysates of control and
treated HepG2 cells. In the present study, the pH 4–7
IPG strips were chosen for 2DE investigation as most ofFigure 3 Representative silver-stained 2DE gel for HepG2 cells
with GTT treatment at pH 4–7. The circled and labelled proteins
(A and B) are the differentially expressed proteins. Both proteins
were exclusively up-regulated during GTT treatment and could not
be detected in the protein profile of control HepG2 cells (without
GTT treatment).
Table 2 Expression pattern for the differentially
expressed proteins in HepG2 cells







A (Prx4) + (∞)
B + (∞)
+ indicates significant up-regulation of protein expression. ∞ indicates
exclusively expressed protein in either control untreated cells or GTT-treated
cells.
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liminary study using pH 3–10 linear IPG strips (data not
shown). The usage of 24 cm pH 4–7 IPG strips improve
the gel resolution in this region.
2DE successfully resolved approximately 1500 protein
spots in all 2DE gels of control and treated HepG2 and
WRL-68 cells. Among these proteins, 15 protein spots
were either up- or down-regulated by more than 2-fold
in HepG2 treated samples versus HepG2 control sam-
ples. Out of five protein spots which showed significant
expression changes, only one protein spot was able to be
identified by MS. This was probably due to low protein
quantity making it difficult to obtain good MS spec-
trums for protein identification. This may be in part due
to the use of silver staining in visualizing the protein
spots on 2DE gels. Silver staining is one of the best
methods for staining 2DE gels because it offers maximal
sensitivity despite being a low cost and easy to handle
procedure. However, silver staining has been reported to
have a rather poor compatibility with MS [24,25]. Modi-
fications of proteins by silver staining may result in low
sequence coverage. Omission of glutaraldehyde increased
sequence coverage, but this improved sequence coverage
especially for low concentration of protein is still not suf-
ficient for secure identification [25]. However, silver
staining was still in this study as it provided the best bal-
ance between sensitivity of protein detection and protein
identification.
A previous study by Aida et al. [5] used the same
treatment condition (48 hr GTT treatment) with HepG2
cells but with a higher GTT dose (170 μM). This re-
sulted in increased Ras protein expression. The present
study however, used a lower GTT dose (70 μM) to
ensure maximum cell viability for the identification of
direct molecular targets of GTT. Prx4 was the only pro-
tein that was identified by MS and was highly expressedTable 3 Peroxiredoxin-4 identification by mass spectrometry
No Protein name Abbreviation Swiss-Prot accession no. pI/MW (E
A Peroxiredoxin 4 Prx 4 Q13162 5.7/33500in HepG2 treated cells. This was a novel observation as
Prx4 has never before been reported in any GTT and
vitamin E anticancer mechanism in general.
Prx4 is ubiquitously expressed and localized in the
endoplasmic reticulum (ER) and extracellular space
[26,27], with highest expression in the pancreas, liver
and heart, and lowest expression in blood leukocytes
and the brain [26,28]. It is overexpressed in lung, pan-
creatic and prostate cancer and has been suggested as a
biomarker candidate for all three cancers [29-31]. In
bladder and triple-negative breast (a subtype of breast
cancer with very poor prognosis) cancer [32], Prx4 was
associated with a poor survival and its selective inhib-
ition may serve as additional option for treatment of
bladder cancer [33].
The up-regulation of Prx has been reported in various
studies in which oxidative stress was involved [34-36].
This up-regulation is a normal cellular response to
reduce the resulting oxidative stress, thus implying the
occurrence of oxidative stress of GTT treatment in the
present study. Kannappan et al. [37] has reported the
induction of ROS generation in colon cancer cells,
HCT-116, within 10 minutes of GTT treatment. These
findings further support the idea of the involvement of
oxidative stress in the effects of GTT treatment. The up-
regulation of Prx4 in this study may be a response to
reduce the threatening effects of increase in ROS or
H2O2 induced by GTT. The observed antiproliferative
effect of GTT may be due the high amount of H2O2
induced by GTT treatment in HepG2 cell. This is sup-
ported by a separate study in our lab using N-acetyl
cycteine (NAC) as the inhibitor for ROS to confirmed
that the action of GTT was through the induction of
H2O2 (unpublished data).
Other studies have also shown that GTT is able to
suppress NF-κB activation resulting in proliferation sup-
pression and apoptosis induction in cancer cells [38,39].
The transcription factor NF-κB regulates a number of
genes that control cell proliferation and cell survival. In
tumor cells, NF-κB is constitutively active resulting in
the continuous expression of genes that keep the cells
proliferating and protecting them from apoptosis. Prx4
has been suggested as an immediate regulator of H2O2-
mediated activation of NF-κB [28]. In addition, it is also
well-established that reactive oxygen intermediates such
as H2O2 can mediate NF-κB activation. NF-κB activation
usually ensures cell proliferation and cell survival. Prx4
may prevent H2O2-induced activation of NF-κB by redu-
cing H2O2 [28,40]. By relating the antioxidant activity ofdata
xperimental) pI/MW (Theoretical) Protein score Peptides (%cov)
5.86/30521 281 6 (36)
Figure 4 Enlargement of Prx4 (spot A) without (control) and
with GTT treatment of HepG2 cells in 2DE gel.
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possible that Prx4 might indirectly help in suppressing
NF-κB activation through H2O2 metabolism. This may
explain the suppression of proliferation in GTT-treated
HepG2 cells observed in this study. Future functional
studies on the functional role of Prx4 may provide in-
sights in determining the relationship between Prx4 and
NF-κB in HepG2 cells.
Quantitative real-time PCR was performed to assess
the mRNA expression of Prx4. The qRT-PCR result
showed that the mRNA expression of Prx4 did not cor-
respond with its protein abundance as observed in 2DE.
This suggested that Prx4 was not regulated at the
mRNA level. In contrast to the increased expression of
Prx4 protein in HepG2 cells after GTT treatment, Prx4
messenger ribonucleic acid (mRNA) was apparently
down-regulated. It has been repeatedly demonstrated
that mRNA levels do not always correlate with protein
expression levels such as that observed in human liver
tissue [41] and capsaicin-treated HepG2 cells [42]. Both
studies emphasized the probabilities of the involvement
of posttranscriptional or posttranslational modifications
and also unknown regulatory mechanisms and signal-
ling. An example of complex regulatory mechanisms in
the expression of drosophila peroxiredoxin I (dPrx I)
where the existence of two alternative 5′UTRs in the
mRNA transcript of dPrx I lead to identical coding se-
quence: namely Ia and Ib [43]. Ia translation is enhanced
in steady-state cells while Ib translation is increased in
cells under oxidative stress. If this kind of complexity is
regulated by the DNA of a mere insect, higher organism
including humans is expected to have a more elaborate
and complex cellular and DNA regulatory mechanisms
that are still unknown. However, with presently available
data, it is not possible to postulate a definite explanation.
Conclusions
In conclusion, our data suggested that the antiprolifera-
tive effect of GTT on HepG2 cells may involve the
change in expression of at least five proteins (up-regula-
tion of two proteins and down-regulation of three pro-
teins). We were able to identify one of these proteins asPrx4. However, the exact manner in which the protein
function triggering or inducing the suppression of prolif-
eration HepG2 cells remains to be elucidated.
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